With a plan to expand its pharmaceutical solutions arm, St. Pete-based engineering and manufacturing giant Jabil recently secured a deal to acquire Pharmaceutics International Inc.

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with ...

Jabil (JBL) announced the acquisition of Pharmaceutics International, completed February 3. “Jabil is very pleased to announce this ...

NLS Pharmaceutics AG’s profitability metrics reveal strong financial health. The company currently boasts a gross margin of -71.63%. The profit margin, also known as the revenue ratio or gross profit ...

Shareholders of the Israeli bio-pharmaceutical startup, Kadimastem Ltd. approved the companys merger with the Swiss ...

NLS Pharmaceutics AG's (NLSP) stock saw a notable increase of 29.79 percent, during Friday morning trading. This surge follows the ...

NLS Pharmaceutics stock is trading higher on Friday after the company announced its merger with Kadimastem has been approved by Kadimastem shareholders.

Kadimastem’s attempt to vault onto Nasdaq is picking up momentum, with shareholders signing off on a merger with NLS Pharmaceutics that would enable the cell therapy developer to recover from last ...

ZURICH and NESS ZIONA, Israel - Shareholders of Kadimastem Ltd. (TASE: KDST), a cell therapy company currently valued at $18.19 million, have approved a merger with Swiss biopharmaceutical firm NLS ...

NLS Pharmaceutics Ltd. ("NLS") (Nasdaq: NLSP), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development ...

NLS Pharmaceutics Ltd. ("NLS") (Nasdaq: NLSP), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for rare and complex central nervous ...

Diagnostic Imaging Agent Market The chronic diseases such as cancer, cardiovascular diseases is a factor driving the growth of the Global D ...